%20(2).webp)
Bioactiv® Matrix is a flagship product by Bioactivx. It is a synthetic 3D-printed, bioactive skin substitute developed for partial-thickness burns and deep abrasion wounds. It received approvals by Singapore’s Health Sciences Authority (HSA) in July 2026.
.svg)
.svg)
.svg)
.svg)
.webp)
Engineered Biomaterial
Supports Cell Attachment & Proliferation
Promotes Tissue Regeneration & Integration
Restores Skin Architecture & Function
No. Bioactiv® Matrix is designed to support natural tissue regeneration without skin grafting when used for its approved indications. Treatment decisions remain subject to the clinician’s assessment of the wound.
No. Bioactiv® Matrix is fully synthetic, acellular and free from animal- and human-derived biological materials.
Not necessarily. Bioactiv® Matrix may be applied in appropriate non-sterile clinical environments, subject to standard wound preparation and local clinical protocols.
No. Bioactiv® Matrix is shelf-stable and does not require refrigeration or cold-chain storage. We recommend to store the product at 25C, dry conditions.
Bioactiv® Matrix is intended for partial-thickness burns, skin-graft donor sites and other wounds covered by the locally approved indications.
No. Bioactiv® Matrix conforms to the wound surface and is held in place with an appropriate secondary dressing.
Singapore: Class C
Malaysia: Class C
Australia: Class C
Europe: Class 2B
USA: Class II
Bioactiv® Matrix is currently available in 5*5 cm; 10*10 cm and 15*20 cm sizes.
Early clinical observations include faster wound closure, earlier re-epithelialisation, lower inflammation and a lower rate of infection compared with the standard-of-care comparator.
Contact us for:
- Clinical evidence summary
- Product information
- Meeting with the Bioactivx® team
.webp)
